应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BK4139 生物科技
交易中 12-16 13:48:00 EST
1,107.42
-10.75
-0.96%
最高
1,119.03
最低
1,103.64
成交量
3.42亿
今开
1,118.17
昨收
1,118.17
日振幅
1.38%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
73.26亿
换手率
--
流通股本
0.00
市净率
7.102734
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Akari Therapeutics宣布500万美元融资,包括同时进行的注册直接发行和按市场价格定价的私募
美股速递 · 12-16 22:31
Akari Therapeutics宣布500万美元融资,包括同时进行的注册直接发行和按市场价格定价的私募
Oncolytics Biotech® 发布支持 Pelareorep 在 KRAS 突变转移性结直肠癌中表现出良好疗效的转化数据
美股速递 · 12-16 22:02
Oncolytics Biotech® 发布支持 Pelareorep 在 KRAS 突变转移性结直肠癌中表现出良好疗效的转化数据
Caris Life Sciences与Genentech开展合作,探索高未满足临床需求癌症的新治疗靶点
美股速递 · 12-16 21:31
Caris Life Sciences与Genentech开展合作,探索高未满足临床需求癌症的新治疗靶点
Cellectar Biosciences与Ionetix达成战略供货协议,以推进靶向α疗法
美股速递 · 12-16 21:06
Cellectar Biosciences与Ionetix达成战略供货协议,以推进靶向α疗法
BioCardia用于缺血性心力衰竭的细胞疗法将正式向日本PMDA进行临床咨询
美股速递 · 12-16 21:05
BioCardia用于缺血性心力衰竭的细胞疗法将正式向日本PMDA进行临床咨询
Palvella Therapeutics 获得 FDA 快速通道认证,用于治疗血管角化瘤的 Qtorin™ 3.9% 干燥雷帕霉素凝胶 (Qtorin™ Rapamycin)
美股速递 · 12-16 20:30
Palvella Therapeutics 获得 FDA 快速通道认证,用于治疗血管角化瘤的 Qtorin™ 3.9% 干燥雷帕霉素凝胶 (Qtorin™ Rapamycin)
NanoViricides Inc(重组前):Alliance Global Partners启动覆盖,给予买入评级;目标价格6美元
美股速递 · 12-16 20:23
NanoViricides Inc(重组前):Alliance Global Partners启动覆盖,给予买入评级;目标价格6美元
天演药业宣布MUZASTOTUG(ADG126)获得FDA快速通道认证
投资观察 · 12-16 20:20
天演药业宣布MUZASTOTUG(ADG126)获得FDA快速通道认证
MapLight获得合作化合物临床开发和商业化的独家权利
美股速递 · 12-16 20:06
MapLight获得合作化合物临床开发和商业化的独家权利
Sandboxaq与MapLight Therapeutics宣布战略合作,共同研发新型中枢神经系统疗法
美股速递 · 12-16 20:01
Sandboxaq与MapLight Therapeutics宣布战略合作,共同研发新型中枢神经系统疗法
Monte Rosa Therapeutics宣布Mrt-2359与恩扎卢胺联合使用在重度预处理的转移性去势抵抗性前列腺癌患者中展现出显著的临床活性
美股速递 · 12-16 20:01
Monte Rosa Therapeutics宣布Mrt-2359与恩扎卢胺联合使用在重度预处理的转移性去势抵抗性前列腺癌患者中展现出显著的临床活性
Tonix Pharmaceuticals获得罗格斯大学授予的选择性Sigma-1受体拮抗剂Tnx-4900的许可,用于慢性神经性疼痛
美股速递 · 12-16 20:01
Tonix Pharmaceuticals获得罗格斯大学授予的选择性Sigma-1受体拮抗剂Tnx-4900的许可,用于慢性神经性疼痛
Aldeyra Therapeutics 股价在盘前交易中下跌14.3%,因其干眼症治疗药物候选获得PDUFA延期
美股速递 · 12-16 17:15
Aldeyra Therapeutics 股价在盘前交易中下跌14.3%,因其干眼症治疗药物候选获得PDUFA延期
Bicycle Therapeutics建立多个战略合作伙伴关系,以构建支持其全资放射药物管道的端到端供应链
美股速递 · 12-16 14:00
Bicycle Therapeutics建立多个战略合作伙伴关系,以构建支持其全资放射药物管道的端到端供应链
Coinbase 将于 12月 16 日 上线 Beam (BEAM) 现货交易
链捕手 · 12-16 09:22
Coinbase 将于 12月 16 日 上线 Beam (BEAM) 现货交易
Aldeyra Therapeutics宣布Reproxalap治疗干眼症的新药申请PDUFA延期
美股速递 · 12-16 08:30
Aldeyra Therapeutics宣布Reproxalap治疗干眼症的新药申请PDUFA延期
Humacyte, Inc. - 高级担保定期贷款设施最高达7750万美元,截止日期为2029年12月1日 - SEC备案
美股速递 · 12-16 05:55
Humacyte, Inc. - 高级担保定期贷款设施最高达7750万美元,截止日期为2029年12月1日 - SEC备案
Humacyte, Inc. - 公司及其子公司与Avenue Venture Opportunities Fund II签订贷款协议 - SEC备案
美股速递 · 12-16 05:54
Humacyte, Inc. - 公司及其子公司与Avenue Venture Opportunities Fund II签订贷款协议 - SEC备案
Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛
美股速递 · 12-16 05:25
Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛
AEON Biopharma与大宇达成1500万美元票据交换协议及累计利息转换为新股权
美股速递 · 12-16 05:09
AEON Biopharma与大宇达成1500万美元票据交换协议及累计利息转换为新股权
加载更多
公司概况
公司名称:
生物科技
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":1107.4233,"timestamp":1765910879930,"preClose":1118.1718,"halted":0,"volume":342244574,"delay":0,"changeRate":-0.009612,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-10.748413,"latestTime":"12-16 13:48:00 EST","open":1118.1702,"high":1119.0292,"low":1103.6414,"amount":7325525443.006609,"amplitude":0.013762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.102734,"peRate":-125.523821,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"1119238470","title":"Akari Therapeutics宣布500万美元融资,包括同时进行的注册直接发行和按市场价格定价的私募","url":"https://stock-news.laohu8.com/highlight/detail?id=1119238470","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119238470?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:31","pubTimestamp":1765895470,"startTime":"0","endTime":"0","summary":"Akari Therapeutics宣布500万美元融资,包括同时进行的注册直接发行和按市场价格定价的私募。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","AKTX"],"gpt_icon":0},{"id":"1124995891","title":"Oncolytics Biotech® 发布支持 Pelareorep 在 KRAS 突变转移性结直肠癌中表现出良好疗效的转化数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1124995891","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124995891?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:02","pubTimestamp":1765893759,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech® 发布支持 Pelareorep 在 KRAS 突变转移性结直肠癌中的良好疗效及转化数据的消息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"1140025630","title":"Caris Life Sciences与Genentech开展合作,探索高未满足临床需求癌症的新治疗靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=1140025630","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140025630?lang=zh_cn&edition=full","pubTime":"2025-12-16 21:31","pubTimestamp":1765891884,"startTime":"0","endTime":"0","summary":"Caris Life Sciences与Genentech开展合作,探索高未满足临床需求癌症的新治疗靶点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"1161773292","title":"Cellectar Biosciences与Ionetix达成战略供货协议,以推进靶向α疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1161773292","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161773292?lang=zh_cn&edition=full","pubTime":"2025-12-16 21:06","pubTimestamp":1765890371,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences与Ionetix达成战略供货协议,提供铀-225和砝-211,以推进靶向α疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"1173911177","title":"BioCardia用于缺血性心力衰竭的细胞疗法将正式向日本PMDA进行临床咨询","url":"https://stock-news.laohu8.com/highlight/detail?id=1173911177","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173911177?lang=zh_cn&edition=full","pubTime":"2025-12-16 21:05","pubTimestamp":1765890342,"startTime":"0","endTime":"0","summary":"BioCardia用于缺血性心力衰竭的细胞疗法将正式向日本PMDA进行临床咨询","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"1132581978","title":"Palvella Therapeutics 获得 FDA 快速通道认证,用于治疗血管角化瘤的 Qtorin™ 3.9% 干燥雷帕霉素凝胶 (Qtorin™ Rapamycin)","url":"https://stock-news.laohu8.com/highlight/detail?id=1132581978","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132581978?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:30","pubTimestamp":1765888255,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics 获得 FDA 快速通道认证,用于治疗血管角化瘤的 Qtorin™ 3.9% 干燥雷帕霉素凝胶 (Qtorin™ Rapamycin)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"1138127754","title":"NanoViricides Inc(重组前):Alliance Global Partners启动覆盖,给予买入评级;目标价格6美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138127754","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138127754?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:23","pubTimestamp":1765887808,"startTime":"0","endTime":"0","summary":"NanoViricides Inc(重组前):Alliance Global Partners启动覆盖,给予买入评级;目标价格6美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"1170910887","title":"天演药业宣布MUZASTOTUG(ADG126)获得FDA快速通道认证","url":"https://stock-news.laohu8.com/highlight/detail?id=1170910887","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170910887?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:20","pubTimestamp":1765887646,"startTime":"0","endTime":"0","summary":"12月16日 - 天演药业(Adagene Inc)宣布,其候选药物MUZASTOTUG(ADG126)已获得美国食品药品监督管理局(FDA)的快速通道认证。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADAG"],"gpt_icon":0},{"id":"1119775214","title":"MapLight获得合作化合物临床开发和商业化的独家权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1119775214","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119775214?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:06","pubTimestamp":1765886772,"startTime":"0","endTime":"0","summary":"MapLight获得合作化合物临床开发和商业化的独家权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"gpt_icon":0},{"id":"1100462384","title":"Sandboxaq与MapLight Therapeutics宣布战略合作,共同研发新型中枢神经系统疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1100462384","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100462384?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:01","pubTimestamp":1765886484,"startTime":"0","endTime":"0","summary":"Sandboxaq与MapLight Therapeutics宣布战略合作,共同研发新型中枢神经系统疗法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"gpt_icon":0},{"id":"1197693110","title":"Monte Rosa Therapeutics宣布Mrt-2359与恩扎卢胺联合使用在重度预处理的转移性去势抵抗性前列腺癌患者中展现出显著的临床活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1197693110","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197693110?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:01","pubTimestamp":1765886479,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics宣布Mrt-2359与恩扎卢胺联合使用在重度预处理的转移性去势抵抗性前列腺癌患者中展现出显著的临床活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE","BK4539","BK4139"],"gpt_icon":0},{"id":"1110103195","title":"Tonix Pharmaceuticals获得罗格斯大学授予的选择性Sigma-1受体拮抗剂Tnx-4900的许可,用于慢性神经性疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1110103195","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110103195?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:01","pubTimestamp":1765886474,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals获得罗格斯大学授予的选择性Sigma-1受体拮抗剂Tnx-4900的许可,用于慢性神经性疼痛","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNXP","BK4583","BK4139"],"gpt_icon":0},{"id":"1168448428","title":"Aldeyra Therapeutics 股价在盘前交易中下跌14.3%,因其干眼症治疗药物候选获得PDUFA延期","url":"https://stock-news.laohu8.com/highlight/detail?id=1168448428","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168448428?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:15","pubTimestamp":1765876524,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics 股价在盘前交易中下跌14.3%,因为其干眼症治疗药物候选获得了PDUFA的延期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"1163131051","title":"Bicycle Therapeutics建立多个战略合作伙伴关系,以构建支持其全资放射药物管道的端到端供应链","url":"https://stock-news.laohu8.com/highlight/detail?id=1163131051","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163131051?lang=zh_cn&edition=full","pubTime":"2025-12-16 14:00","pubTimestamp":1765864811,"startTime":"0","endTime":"0","summary":"Bicycle Therapeutics建立多个战略合作伙伴关系,以构建支持其全资放射药物管道的端到端供应链","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCYC","BK4139"],"gpt_icon":0},{"id":"2591022676","title":"Coinbase 将于 12月 16 日 上线 Beam (BEAM) 现货交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2591022676","media":"链捕手","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591022676?lang=zh_cn&edition=full","pubTime":"2025-12-16 09:22","pubTimestamp":1765848170,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,Coinbase Markets 宣布将于 2025 年 12 月 16 日上线 Beam (BEAM) 现货交易,BEAM-USD 交易对将在当日太平洋时间 9:00 之后、流动性条件满足的情况下开放,适用于支持交易的地区。 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2229897","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","BK4516","BK4588","LU1861220207.SGD","BK4112","BK4139","BK4595","BK4551","BK4535","BK4539","BK4600","LU1861558580.USD","BK4554","BK4596","BK4556","BK4611","BK4505","LU1861559042.SGD","LU2360107671.USD","LU1861217088.USD","BK4585"],"gpt_icon":0},{"id":"1198726583","title":"Aldeyra Therapeutics宣布Reproxalap治疗干眼症的新药申请PDUFA延期","url":"https://stock-news.laohu8.com/highlight/detail?id=1198726583","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198726583?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:30","pubTimestamp":1765845015,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics宣布Reproxalap治疗干眼症的新药申请PDUFA延期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"1174874392","title":"Humacyte, Inc. - 高级担保定期贷款设施最高达7750万美元,截止日期为2029年12月1日 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1174874392","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174874392?lang=zh_cn&edition=full","pubTime":"2025-12-16 05:55","pubTimestamp":1765835710,"startTime":"0","endTime":"0","summary":"Humacyte, Inc. - 高级担保定期贷款设施最高达7750万美元,截止日期为2029年12月1日 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4139","HUMA"],"gpt_icon":0},{"id":"1180140779","title":"Humacyte, Inc. - 公司及其子公司与Avenue Venture Opportunities Fund II签订贷款协议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1180140779","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180140779?lang=zh_cn&edition=full","pubTime":"2025-12-16 05:54","pubTimestamp":1765835651,"startTime":"0","endTime":"0","summary":"Humacyte, Inc. - 公司及其子公司与Avenue Venture Opportunities Fund II签订贷款协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","HUMA"],"gpt_icon":0},{"id":"1101439563","title":"Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1101439563","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101439563?lang=zh_cn&edition=full","pubTime":"2025-12-16 05:25","pubTimestamp":1765833911,"startTime":"0","endTime":"0","summary":"Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORGO"],"gpt_icon":0},{"id":"1182438992","title":"AEON Biopharma与大宇达成1500万美元票据交换协议及累计利息转换为新股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1182438992","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182438992?lang=zh_cn&edition=full","pubTime":"2025-12-16 05:09","pubTimestamp":1765832948,"startTime":"0","endTime":"0","summary":"AEON Biopharma与大宇达成1500万美元票据交换协议及累计利息转换为新股权","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}